| CIBR | NBDS | CIBR / NBDS | |
| Gain YTD | 28.928 | 9.513 | 304% |
| Net Assets | 13.9B | 143M | 9,720% |
| Total Expense Ratio | 0.58 | 0.40 | 145% |
| Turnover | 21.00 | 34.00 | 62% |
| Yield | 0.44 | 0.00 | - |
| Fund Existence | 11 years | 4 years | - |
| CIBR | NBDS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 89% | N/A |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 86% |
| Momentum ODDS (%) | 3 days ago 89% | 3 days ago 80% |
| MACD ODDS (%) | 3 days ago 89% | 3 days ago 69% |
| TrendWeek ODDS (%) | 3 days ago 86% | 3 days ago 76% |
| TrendMonth ODDS (%) | 3 days ago 87% | 3 days ago 78% |
| Advances ODDS (%) | N/A | 18 days ago 87% |
| Declines ODDS (%) | N/A | 3 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 83% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 86% | 3 days ago 78% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBH | 205.55 | N/A | N/A |
| VanEck Biotech ETF | |||
| GMOM | 36.68 | N/A | N/A |
| Cambria Global Momentum ETF | |||
| MQQQ | 237.46 | N/A | N/A |
| Tradr 2X Long Innovation 100 Monthly ETF | |||
| NEMG | 14.06 | N/A | N/A |
| Leverage Shares 2X Long Nem Daily ETF | |||
| EXG | 9.50 | -0.02 | -0.21% |
| Eaton Vance Tax-Managed Global Diversified Equity Income Fund | |||
A.I.dvisor tells us that NBDS and ONTO have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBDS and ONTO's prices will move in lockstep.
| Ticker / NAME | Correlation To NBDS | 1D Price Change % | ||
|---|---|---|---|---|
| NBDS | 100% | -2.08% | ||
| ONTO - NBDS | 17% Poorly correlated | -6.40% | ||
| GTM - NBDS | 12% Poorly correlated | +1.39% | ||
| ARM - NBDS | 10% Poorly correlated | -8.14% | ||
| TDG - NBDS | 9% Poorly correlated | +1.88% | ||
| RDDT - NBDS | 9% Poorly correlated | -0.03% | ||
More | ||||